EUVIMEDEUVIMED entdecken
Open Access

Senescence‑associated IL‑33 secretion undermines sorafenib efficacy in hepatocellular carcinoma via immune evasion

Yu-Xin Lin, Hsien Liu, Wei-Chiao Liao, Yi-Ching Wang, Bo-Cheng Zhang, Shu-Wen Wan, Chien-Chin Chen, Chih-Peng Chang

Oncology Reports · 2025

DOI: 10.3892/or.2025.8987 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Reports, 2025. Verfasst von Yu-Xin Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan. Hauptthemen laut MEDLINE: Sorafenib, Carcinoma, Hepatocellular, Liver Neoplasms, Interleukin-33. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SorafenibCarcinoma, HepatocellularLiver NeoplasmsInterleukin-33Drug Resistance, NeoplasmHumansAnimalsMiceXenograft Model Antitumor AssaysB7-H1 AntigenCell Line, TumorCellular SenescencePhenylurea CompoundsPyridinesSignal TransductionMaleGene Expression Regulation, NeoplasticCell Proliferation

Stichwörter der Autor:innen

hepatocellular carcinomainterleukin‑33programmed death ligand 1regorafenibsorafenib

Substanzen

SorafenibB7-H1 AntigenInterleukin-33Phenylurea CompoundsPyridinesregorafenibCD274 protein, human

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
  • Division of General Surgery, Department of Surgery, Ditmanson Medical Foundation Chia‑Yi Christian Hospital, Chiayi 60002,Taiwan.
  • Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan 70101, Taiwan.
  • Department of Pathology, Ditmanson Medical Foundation Chia‑Yi Christian Hospital, Chiayi 60002, Taiwan.

Zitieren

APA

Lin, Y. X., Liu, H., Liao, W. C., Wang, Y. C., Zhang, B. C., Wan, S. W., Chen, C. C., & Chang, C. P. (2025). Senescence‑associated IL‑33 secretion undermines sorafenib efficacy in hepatocellular carcinoma via immune evasion. Oncology Reports. https://doi.org/10.3892/or.2025.8987

Vancouver

Lin YX, Liu H, Liao WC, Wang YC, Zhang BC, Wan SW, et al. Senescence‑associated IL‑33 secretion undermines sorafenib efficacy in hepatocellular carcinoma via immune evasion. Oncology Reports. 2025. doi:10.3892/or.2025.8987

BibTeX
@article{Lin2025,
  author = {Lin, Yu-Xin and Liu, Hsien and Liao, Wei-Chiao and Wang, Yi-Ching and Zhang, Bo-Cheng and Wan, Shu-Wen and Chen, Chien-Chin and Chang, Chih-Peng},
  title = {Senescence‑associated IL‑33 secretion undermines sorafenib efficacy in hepatocellular carcinoma via immune evasion},
  journal = {Oncology Reports},
  year = {2025},
  doi = {10.3892/or.2025.8987}
}
Kostenlos starten →